Clinical trial
OSI-774 in African American Patients With Advanced and Previously Treated…
NCT00230126 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00230126 |
|---|---|
| Title | OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer |
| Official title | A Phase II Randomized Study of OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | erlotinib |
| Enrollment | 57 |
| Start date | Oct 1, 2005 |
| Primary completion | Sep 1, 2011 |
| Completion | Jul 1, 2013 |
| First posted | Sep 30, 2005 |
| Last update posted | Dec 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: